MOKARI ATABAK (Chief Financial Officer) received a stock award from CORCEPT THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 9/4/2026ACC: 0001193125-26-382463
Officer· Chief Financial Officer
Since Mar 2021
+174.00
Net shares
Net buyer
$11.6K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
276.00 acquired · 102.00 disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+138.00
Price / share
$113.38
Trade value
$15.65K
% of position
0.9%
9/1/2026
16.13K→16.27K
Common Stock
Direct
Shares
+138.00
Price / share
—
Trade value
—
% of position
0.8%
9/1/2026
16.27K→16.41K
Common Stock
Direct
Shares
−102.00
Price / share
$113.38
Trade value
$11.56K
% of position
0.6%
9/2/2026
16.41K→16.30K
Total
Net shares
+174.00
Net value
$4.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | A · Award | +138.00 | $113.38 | $15.65K | 0.9% | 16.13K | 16.27K |
| Common Stock Direct | 9/1/2026 | A · Award | +138.00 | — | — | 0.8% | 16.27K | 16.41K |
| Common Stock Direct | 9/2/2026 | F · Tax Withholding | −102.00 | $113.38 | $11.56K | 0.6% | 16.41K | 16.30K |
| Total | +174.00 | $4.08K | ||||||
Derivative Transactions0
No derivative transactions reported